Andreas Hillarp
81 – 90 of 119
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2001
-
Mark
Ny in vitro-analys prövad: Blödningstid fortfarande bästa metod för test av den primära hemostasen
(
- Contribution to journal › Article
-
Mark
Combined effect of factor V Leiden and prothrombin 20210A on the risk of venous thromboembolism : Pooled analysis of 8 case-control studies including 2310 cases and 3204 controls
(
- Contribution to journal › Article
- 2000
-
Mark
Använd hela "analyspaketet" vid utredning av trombospatienten! Och glöm inte släktingarna ...
(
- Contribution to journal › Article
-
Mark
Hyperhomocysteinemia and the MTHFR C677T mutation in central retinal vein occlusion
(
- Contribution to journal › Article
- 1999
-
Mark
Changes in levels of factor VII and protein S after acute myocardial infarction: effects of low-dose warfarin
(
- Contribution to journal › Article
-
Mark
Factor V Q506 (resistance to activated protein C) and prognosis after acute coronary syndrome
(
- Contribution to journal › Article
-
Mark
Thrombophilia as a multigenic disease
(
- Contribution to journal › Article
-
Mark
Activated protein C resistance and anticoagulant proteins in young adults with central retinal vein occlusion
(
- Contribution to journal › Article
-
Mark
The prothrombin gene G20210A mutation and the platelet glycoprotein IIIa polymorphism PlA2 in patients with central retinal vein occlusion
(
- Contribution to journal › Article
-
Mark
Samordnad svensk övergång rekommenderas under 1999. Protrombinkomplexmätning bör anges som en kvot, inte i procent
(
- Contribution to journal › Article